Evidence map›Paper›PMID 24577087›Full record

ArticleCell death & disease2014

Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence.

D Gitenay, C Wiel, H Lallet-Daher, D Vindrieux, S Aubert, L Payen, H Simonnet, D Bernard

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Mitochondrial regulation of cellular senescence heterogeneity.Frontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Branched-Chain Amino Acid Accumulation Fuels the Senescence-Associated Secretory Phenotype.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

D Gitenay1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France.
C Wiel1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France.
H Lallet-Daher1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France.
D Vindrieux1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France.
S Aubert1] Institut de Pathologie, CHRU, Faculté de Médecine, Université de Lille, Lille, France [2] Inserm U837, Jean-Pierre Aubert Research Center, Team 5, Lille, France.
L Payen1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France [5] Biochemistry Laboratory of Lyon Sud, Hospices civils de Lyon, Lyon, France.
H Simonnet1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France.
D Bernard1] Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France [2] CNRS UMR5286, Lyon, France [3] Centre Léon Bérard, Lyon, France [4] Université de Lyon, Lyon, France.
Université Claude Bernard Lyon 1 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oncogenic stress-induced senescence (OIS) prevents the ability of oncogenic signals to induce tumorigenesis. It is now largely admitted that the mitogenic effect of oncogenes requires metabolic adaptations to respond to new energetic and bio constituent needs. Yet, whether glucose metabolism affects OIS response is largely unknown. This is largely because of the fact that most of the OIS cellular models are cultivated in glucose excess. In this study, we used human epithelial cells, cultivated without glucose excess, to study alteration and functional role of glucose metabolism during OIS. We report a slowdown of glucose uptake and metabolism during OIS. Increasing glucose metabolism by expressing hexokinase2 (HK2), which converts glucose to glucose-6-phosphate (G6P), favors escape from OIS. Inversely, expressing a glucose-6-phosphatase, [corrected] pharmacological inhibition of HK2, or adding nonmetabolizable glucose induced a premature senescence. Manipulations of various metabolites covering G6P downstream pathways (hexosamine, glycolysis, and pentose phosphate pathways) suggest an unexpected role of the hexosamine pathway in controlling OIS. Altogether, our results show that decreased glucose metabolism occurs during and participates to OIS.

Indexed as

Cellular SenescenceEnergy MetabolismOncogenesCells, CulturedEnzyme InhibitorsEpithelial CellsFemaleGlucoseGlucose-6-PhosphateGlycolysisHexokinaseHexosaminesHumansKineticsMammary Glands, HumanPentose Phosphate PathwayEnzyme InhibitorsGlucoseGlucose-6-PhosphateHexokinaseHexosamines

Identifiers

PMID24577087
PMCPMC3944274
OpenAlexW2006629499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.